Quince Therapeutics S.p.A.
10 clinical trials · Sponsor
◉ Watch Quince Therapeutics S.p.A.
| Record | Firm | Date |
|---|---|---|
| Open-Label Extension of EryDex Study IEDAT-04-2022 (NCT06664853) | Quince Therapeutics S.p.A. | 2024-12-11 |
| Evaluate the Neurological Effects of EryDex on Subjects With A-T (NCT06193200) | Quince Therapeutics S.p.A. | 2024-06-24 |
| Extension Treatment Using EryDex System in Patients With AT Who Participated in the ATTeST-IEDAT-02-2015 Study (NCT03563053) | Quince Therapeutics S.p.A. | 2018-06-12 |
Track Quince Therapeutics S.p.A. automatically
Every clearance here is in the API, with alerts when new ones post.